Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN)

Current Treatment Options in Oncology

Volumn 8, Issue 3, 2007, Pages 252-260

  Kies, Merrill S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; LARYNGECTOMY; LARYNX CANCER; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; ORGAN PRESERVATION; OVERALL SURVIVAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; REMISSION INDUCTION; TAXOIDS;

EID: 38349076589     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-007-0035-z     Document Type: Article

References (35)

1. Adelstein DJ: Induction chemotherapy in head and neck cancer. Hematol Oncol Clin North Am 1999, 13(4):689-698
2. Cohen EE, Lingen MW, Vokes EE: The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 2004, 22(9):1743-1752
3. Forastiere AA, Goepfert H, Maor M, et al.: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349(22):2091-2098
4. Merlano M, Vitale V, Rosso R, et al.: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992, 327(16):1115-1121
5. Calais G, Alfonsi M, Bardet E, et al.: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91(24):2081-2086
6. Jeremic B, Shibamoto Y, Milicic B, et al.: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 2000, 18(7):1458-1464
7. Brizel DM, Albers ME, Fisher SR, et al.: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338(25):1798-1804
8. Wendt TG, Grabenbauer GG, Rodel CM, et al.: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998, 16(4):1318-1324
9. Staar S, Rudat V, Stuetzer H, et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001, 50(5):1161-1171
10. Adelstein DJ, Li Y, Adams GL, et al.: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003, 21(1):92-98
11. Huguenin P, Beer KT, Allal A, et al.: Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004, 22(23): 4665-4673. Epub 2004 Nov 8
12. Budach V, Stuschke M, Budach W, et al.: Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005, 23(6):1125-1135
13. Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000, 355(9208):949-955
14. Ang KK: Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: Are we addressing burning subjects? J Clin Oncol 2004, 22(23):4605-4607
15. Monnerat C. Faivre S, Temam S, et al: End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Annal Oncol 2002, 13: 995-1006
16. Brockstein B, Haraf DJ, Rademaker AW, et al.: Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004, 15(8):1179-1186
17. Adelstein DJ, Leblanc M: Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? J Clin Oncol 2006, 24(17):2624-2628
18. Wolf GT et al. (The Department of Veterans Affairs Laryngeal Cancer Study Group): Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991, 324(24): 1685-1690
19. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T: Larynx preservation in pyrifoPm sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 1996, 88(13):890-899
20. Calais G, Pointreau Y, Alfonsi M, et al.: Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. Proc Am Soc Clin Onc 2006, 24(No18S):5506
21. Forastiere AA, Maor M, Weber RS, et al.: Long-term results of intergroup RTOG 91-11: A phase III trial to preerve the larynx-Induction cisplatin/ 5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus therapy. Proc Am Soc Clin Onc 2006, 24(No18S):5517
22. Urba S, Wolf G, Eisbruch A, et al.: Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: A new treatment paradigm. J Clin Oncol 2006, 24:593-598
23. Laccourreye O, Brasnu D, Bassot V, et al.: Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete responders: Five-year results. J Clin Oncol 1996, 14(8):2331-2336
24. Kies MS, Sturgis E, Sabichi A, et al.: Induction chemotherapy followed by surgical resection for young patients with squamous cell carcinoma of the oral tongue (SCC/T). Proc Am Soc Clin Oncol 2005, 23(No 16S):5515
25. Paccagnella A, Orlando A, Marchiori C, et al.: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994, 86(4):265-272
26. Domenge C, Hill C, Lefebvre JL, et al.: Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer 2000, 83(12):1594-1598
27. Posner MR: Paradigm shift in the treatment of head Tnd neck cancer: the role of neoadjuvant chemotherapy. Oncologist 2005, 10(Suppl 3):11-19
28. Posner MR, Colevas AD, Tishler RB: The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Semin Oncol 2000, 27(4 Suppl 8):13-24
29. Kies MS, Haraf DJ, Athanasiadis I, et al.: Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 1998, 16(8):2715-2721
30. Haddad R, Tishler RB, Norris CM, et al.: TPF-based induction chemotherapy for head and neck cancer and the case for sequential, combined modality treatment. Oncologist 2003, 8: 35-44
31. Haddad R, Wirth L, Posner M: The integration of chemotherapy in the curative treatment of locally advanced head and neck cancer. Expert Rev Anticancer Ther 2003, 3:331-338
32. Machtay M, Rosenthal DI, Hershock D, et al.: Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania Phase II Trial. J Clin Oncol 2002, 20(19):3964-3971
33. Hitt R, Lopez-Pousa A, Martinez-Trufero J, et al.: Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005, 23(34):8636-8645
34. Vermorken JB, Remenar E, van Herpen C, et al: Standard cisplatin/ infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck: A phase III trial of the EORTC head and neck cancer group (EPORTC #24971). J Clin Oncol 2004, 22: 490s, (suppl. abstr 5508)
35. Posner M: Sequential combined modality therapy a phase III study: TAX 324 TPF vs PF followed by chemoradiotherapy. Special presentation. American Society of Clinical Oncology Meeting; Atlanta, Georgia, 2006